Clomiphene
In clinical developmentAlso known as Clomid, Clomifeno, Clomifenum, Milophene+5 more
Clomid, Clomifeno, Clomifenum, Milophene, Serophene, Clomifene, 2-(4-(2-chloro-1,2-diphenylethenyl)phenoxy)-N,N-diethylethanamine, 2-(p-(2-chloro-1,2-diphenylvinyl)phenoxy)triethylamine, ClomiPHENE Citrate.
Recent clinical, regulatory, research and industry developments relating to this drug.
Sex Hormone Supplementation and Rotator Cuff Repair: A Preliminary Randomized Trial
Induction of Ovulation With Raloxifene or Clomiphene Citrate in Polycystic Ovarian Syndrome
Letrozole versus clomiphene for infertility in the polycystic ovary syndrome.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Recent completions
Trials that read out recently, adding to the completed evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Journals, researchers & institutions
- The New England journal of medicine1
- Alvero R1
- Baker V1
- Barnhart KT1
- Bates GW1
- Brzyski RG1
- Casson P1
- Christman GM1
- Coutifaris C1
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across 2 of the same disease areas as Clomiphene in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials